About the Paranasal Sinus Cancer Session
Paranasal sinus cancer, though rare, presents significant challenges in both diagnosis and treatment. These cancers originate in the nasal cavity and sinuses, often diagnosed at an advanced stage due to their subtle symptoms like congestion or facial pain. Research in this area focuses on improving early detection methods, such as imaging techniques and biomarker identification, to enable timely interventions.
Furthermore, advancements in treatment modalities like surgery, radiation therapy, and chemotherapy aim to enhance outcomes and preserve quality of life for patients. Immunotherapy and targeted therapies also hold promise in addressing specific genetic mutations driving these cancers. Collaborative efforts between oncologists, surgeons, and researchers are vital in unraveling the complexities of paranasal sinus cancer and devising more effective strategies to combat it.
Topics Covered in Paranasal Sinus Cancer
Sinonasal Adenocarcinoma
Olfactory Neuroblastoma
Mucosal Melanoma
Occupational Risk Factors
Endoscopic Resection
Proton Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Paranasal Sinus Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Paranasal Sinus Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Paranasal Sinus Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Paranasal Sinus Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Paranasal Sinus Cancer Conference 2027 — FAQs
What is the Paranasal Sinus Cancer track at CIOC 2027?
The Paranasal Sinus Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Paranasal Sinus Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Paranasal Sinus Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Paranasal Sinus Cancer are all welcome — whether presenting or attending.
Can I present my research in the Paranasal Sinus Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Paranasal Sinus Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Paranasal Sinus Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.